首页> 外国专利> METHOD FOR DIFFERENTIAL DIAGNOSTICS OF CERVICAL INTRAEPITHELIAL NEOPLASIAS ASSOCIATED WITH HUMAN PAPILLOMA VIRUS OF HIGH ONCOGENIC RISK

METHOD FOR DIFFERENTIAL DIAGNOSTICS OF CERVICAL INTRAEPITHELIAL NEOPLASIAS ASSOCIATED WITH HUMAN PAPILLOMA VIRUS OF HIGH ONCOGENIC RISK

机译:与高致癌风险的人乳头瘤病毒相关宫颈椎间盲瘤的鉴别诊断方法

摘要

FIELD: medicine.;SUBSTANCE: invention relates to the field of medicine, in particular, to gynecology, and is intended for differential diagnostics of cervical intraepithelial neoplasias associated with human papilloma virus of high oncogenic risk. The amount of cells with the CD3+CD4+PD1+TIM3+ and CD3+CD4+PD1+LAG3+ phenotype in the general population of CD3+CD4+ T-lymphocytes is determined in an immunological study. If the amount of cells with said phenotype in each of the variants is less than 2% of the total population of CD3+CD4+ T-lymphocytes, I degree cervical intraepithelial neoplasia is diagnosed. If the amount of cells with said phenotype in each of the variants is 2 to 5% in the total population of CD3+CD4+ T-lymphocytes, II degree cervical intraepithelial neoplasia is diagnosed. If the amount of cells with said phenotype in each of said cases is greater than 5%, III degree cervical intraepithelial neoplasia is diagnosed. ;EFFECT: invention ensures determination and differentiation of the degree of development of cervical intraepithelial neoplasia and a reduction in the duration of stay of patients in the in-patient facility.;1 cl, 4 ex
机译:田地:药物。物质:发明涉及医学领域,尤其涉及妇科,并且旨在鉴于与高致癌风险的人乳头瘤病毒相关的宫颈上皮内瘤瘤的鉴别诊断。在免疫研究中确定了CD3 + CD4 + PD1 + TIM3 +和CD3 + CD4 + PD1 + LAG3 +表型的细胞的量。如果在每个变体中具有所述表型的细胞量小于CD3 + CD4 + T淋巴细胞总群的2%,则诊断宫颈上皮内瘤瘤。如果每个变体中具有所述表型的细胞的量为CD3 + CD4 + T淋巴细胞的总群中的2至5%,则诊断II度宫颈上皮内瘤周期。如果在所述患者中的每种情况下具有所述表型的细胞量大于5%,则诊断III度宫颈上皮内瘤周期。 ;效果:发明确保宫颈上皮内瘤形成的发育程度的测定和分化以及患者内部设施患者的患者持续时间减少。; 1 CL,4 EX

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号